The perfect successor to Rick & Morty arrived on Netflix in 2021, and it should have been treated with much more respect by ...
はじめに 個人開発で運用している株式分析のWebアプリで、ログインの仕組みを大きく入れ替えました。これまでは「メールアドレスとパスワード」で入る、よくある自前の認証だったのですが、これを AWS が提供するマネージドな認証基盤(Cognito)に載せ替えた、という話です。 技術記事は別に書いたので、こちらは 「なぜやったのか」「どう段階を切ったのか」「何を壊さないよう守ったのか」 という意思決定の ...
IntroductionI have significantly replaced the login mechanism for a stock analysis web app that I operate as a personal ...
A well-known comedian died on stage at the Lone Wolf Comedy Club in Bicester, Oxfordshire, in front of his audience ...
Ian Cognito's real name was Paul Barbieri -Credit:Reach Publishing Services Limited When the audience filed into the Lone Wolf Comedy Club on that fateful evening in 2019, nobody could have ...
British comedian Tommy Cooper tragically died on April 15, 1984, at age 63, after suffering a massive heart attack on live television during the variety show Live From Her Majesty's in London. The ITV ...
New data from Cognito Therapeutics has indicated that its Spectris device increases cerebrospinal fluid (CSF) HDL-like lipid transport particles, suggesting the neuromodulation therapy prompts a ...
Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced a partnership with the Initiative ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced ...
Collaboration expands national initiative designed to accelerate the discovery, validation, and delivery of non-invasive neuroprotective therapies Cognito Therapeutics, a late clinical-stage ...
Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer's disease therapeutic. The Massachusetts-based company's oversubscribed Series C ...
Cognito Therapeutics, a late clinical-stage neurotechnology company developing non-invasive therapies for neurodegenerative diseases, announced the close of an oversubscribed $105 million Series C ...